CinCor Pharma

About:

CinCor is a clinical-stage biopharmaceutical company that develops treatments for cardiovascular diseases.

Top Investors: General Atlantic, Perceptive Advisors, Sofinnova Investments, CinRx Pharma, Biotechnology Value Fund

Description:

CinCor is a clinical-stage biopharmaceutical company with a mission to advance promising clinical candidates toward marketing approval. CinCor’s focus is on cardiovascular, metabolic and kidney diseases. CinCor has program is CIN-107, a novel aldosterone synthase inhibitor.

Total Funding Amount:

$418M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Cincinnati, Ohio, United States

Founded Date:

2018-01-01

Contact Email:

info(AT)cincor.com

Founders:

Catherine Pearce, Jon Isaacsohn

Number of Employees:

11-50

Last Funding Date:

2022-08-11

IPO Status:

Public

Industries:

Biotechnology

Pharmaceutical

Therapeutics